Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results

Core Insights - Waterdrop Inc. reported significant profit growth in Q3 2025, with operating profit reaching RMB 113.8 million (US$ 16.0 million), a year-over-year increase of 329.8% [1] - The company experienced rapid revenue expansion, with net operating revenue of RMB 974.9 million (US$ 136.9 million), up 38.4% year-over-year [1] - The insurance-related income surged to RMB 869.7 million (US$ 122.2 million), reflecting a 44.8% increase from the same period in 2024 [1] Financial Highlights - Operating profit for Q3 2025 was RMB 113.8 million (US$ 16.0 million), compared to RMB 26.5 million in Q3 2024 [2] - Net profit attributable to ordinary shareholders was RMB 158.5 million (US$ 22.3 million), a 60.1% increase year-over-year [1] - Adjusted net profit for Q3 2025 was RMB 167.7 million (US$ 23.6 million), up from RMB 126.0 million in Q3 2024 [3] Revenue Breakdown - Insurance segment revenue was RMB 869.7 million (US$ 122.2 million), a 44.8% increase year-over-year [1] - Crowdfunding service fees remained stable at RMB 65.7 million (US$ 9.2 million), nearly unchanged from RMB 65.8 million in Q3 2024 [1] - Digital clinical trial solution income rose to RMB 31.9 million (US$ 4.5 million), marking a 31.3% increase from the previous year [1] Cost and Expense Analysis - Operating costs and expenses increased by 27.1% year-over-year to RMB 861.1 million (US$ 121.0 million) [1] - Sales and marketing expenses rose by 40.3% year-over-year to RMB 243.0 million (US$ 34.1 million) [1] - General and administrative expenses decreased by 23.7% year-over-year to RMB 84.7 million (US$ 11.9 million) [1] Operational Developments - The company enrolled 13,282 patients into 1,491 clinical trial programs through its E-Find Platform as of September 30, 2025 [1] - Waterdrop Medical Crowdfunding facilitated donations totaling RMB 71.2 billion to 3.61 million patients [1] - The company repurchased approximately 58.1 million ADSs from the open market, totaling around US$ 113.4 million as of November 30, 2025 [1]